共查询到20条相似文献，搜索用时 15 毫秒
1.
2.
Cohen J 《Science (New York, N.Y.)》2004,304(5670):504-509
3.
Cohen J 《Science (New York, N.Y.)》2011,334(6061):1338-1340
4.
Shelton JD 《Science (New York, N.Y.)》2011,334(6063):1645-1646
5.
Cohen J 《Science (New York, N.Y.)》2005,309(5737):1003
6.
7.
8.
9.
10.
11.
J Cohen 《Science (New York, N.Y.)》2012,337(6094):509-510
12.
13.
Bloom DE 《Science (New York, N.Y.)》2000,288(5474):2171-2173
Largely because of disparities in access to drug treatment and care, AIDS morbidity and mortality have fallen in the developed world but continue to rise among developing countries. Achieving more equitable access to AIDS drugs is hindered by high drug prices, technical complexities related to the provision of health care, and conflict among stakeholders. Recognition that health is vital to the prospects of the emerging global society must be combined with new mechanisms to help all stakeholders work together cooperatively. Tiered drugs pricing should be coupled with investment in health services. An independent "Global Task Force," able to act as an "active think tank," could build consensus about the way forward. 相似文献
14.
15.
16.
17.
18.
19.
20.